Fiebig created his core team who has a palette of skills and certain experiences to cover many different domains. Heinz-Herbert Fiebig, the Founder and CEO of 4HF Biotec GmbH together with his skilled team overcome this issue through their sheer commitment and passion.
Its main obstacle was the need to cover many aspects of the business with shoestring human resources that involve right from basic science to business development and communication or recruiting. Similarly, 4HF also faced various trials and tribulations to reach where it is positioned today. After conquering these challenges, they move towards success, growth, and development. In the initial days, every organization faces various different and complex challenges. Conquering Challenges with Team Work and Effort At the same time, it offers services for pharma and biotech companies generating revenues.
The company believes that its flagship technology platform can be used for its drug discovery and developments partly with cooperation partners or investors. 4HF has been working on developing programs to identify biomarkers predicting sensitivity or resistance of a targeted drug. More importantly, its research is based on integrative analysis of cancer information and aims to identify treatments that more specifically target cancer cells and limit side effects.įurthermore, the leading biotech company has completed the programming of evaluation programs and visualization for tumor-selective genes/targets. Databases of tumor models (proprietary), patient tumors, and normal tissues being fully characterized for gene expression, mutations, copy number alterations, and gene fusions help in studying the huge heterogeneity of cancers. It also provides new tools and analysis to develop so-called precision medicine as well as notably to well predict the right treatment for each patient. These valuable databases offer the opportunity to realize real progress in cancer treatment. To make more efficient treatments for cancer patients, 4HF uses its expertise in the assembly of cancer-related databases offering an unprecedented amount of data and new ways of analyzing cancers. Leveraging Data Mining to Make More Efficient Cancer Treatments Since its inception, the company specializes in bioinformatics and data analytics for discovery of innovative therapies to treat cancers. It has built a unique proprietary database and set up a dedicated platform to interrogate cancers throughout their huge diversities. The company primarily focuses on three key axes: discovery of new druggable targets, identification of companion diagnostics, and evaluation of novel anticancer drugs. It is also collaborating with academia, biotech and pharmaceutical companies in preclinical cancer research. Using these strategies, the company will improve the evaluation of novel anticancer drugs at the preclinical stage. Headquartered in Freiburg, 4HF Biotec GmbH has been addressing this challenge by leveraging data mining-based strategies for cancer drug discovery. Therefore, it is of utmost importance to discover more efficient and less toxic cancer therapies which remain a major challenge.
However, current therapies are efficient in a restricted amount of patients and are linked to side effects and the development of resistance. Innovations in cancer treatments aim to tackle a number of problems typically encountered by health care providers and patients, including aggressive therapy accompanied by unwanted side effects, tumor recurrence after treatment, surgery, or both, and aggressive cancers that are resilient to commonly used medicines. Today, many cancer treatments are available to help cancer patients live a normal life span.
0 kommentar(er)
